No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Alleles
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Cyclophosphamide / administration & dosage
-
Dexamethasone / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Follow-Up Studies
-
GATA3 Transcription Factor / genetics*
-
Genetic Association Studies
-
Genetic Predisposition to Disease
-
Germ-Line Mutation
-
Hispanic or Latino / genetics
-
Humans
-
Kaplan-Meier Estimate
-
Male
-
Polymorphism, Single Nucleotide*
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / ethnology
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / mortality
-
Prognosis
-
Receptors, Cytokine / genetics*
-
Risk Factors
-
Vincristine / administration & dosage
-
Young Adult
Substances
-
CRLF2 protein, human
-
GATA3 Transcription Factor
-
GATA3 protein, human
-
Receptors, Cytokine
-
Vincristine
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide
-
Asparaginase